The number of young people in the U.S. with type 2 diabetes could surge by about 700% over the next four decades, with a greater burden falling on minority groups, a new model predicts. If the recent ...

Prediabetes increases a person's risk of developing Type 2 diabetes. An estimated 1 in 3 teens and preteens, ages 12 to 17, have prediabetes, according to new data from the Centers for Disease Control ...

A new federal estimate shows a rise in prediabetes among American adolescents, a finding that is spurring concerns about the health of U.S. children — and the way Trump administration health officials ...

STATEN ISLAND, N.Y. -- Nearly two million New Yorkers have been diagnosed with diabetes, but the disease is much more prevalent in some parts of the state, like Staten Island, than others. On Staten ...

As the first dual SGLT1/SGLT2 inhibitor developed for use in diabetes, Lexicon’s sotagliflozin has tantalizing potential. But getting the pill to pass muster with the FDA has been problematic. The ...

A new study has shown that Mounjaro, a GLP-1-based drug, can significantly reduce blood sugar levels and support weight loss in children as young as 10 years old who are living with type 2 diabetes, ...

An interdisciplinary team of researchers from the University of Missouri, Children's Mercy Kansas City and Texas Children's Hospital has used a new data-driven approach to learn more about persons ...

Participants who received the highest dose showed a meaningful drop in blood sugar, with average A1C levels declining by 1.8% from a baseline of 8.1%. Notably, three-quarters of patients on the 36mg ...

Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's previously submitted additional data on its experimental drug, zynquista, for ...

(Reuters) -Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's previously submitted additional data on its experimental drug, ...